Actively Recruiting
Serum Collection Study for Assay Development
Led by GPN Vaccines · Updated on 2025-10-03
12
Participants Needed
1
Research Sites
34 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study will collect serum from 12 participants vaccinated with Gamma-PN to assist with assay development and validation
CONDITIONS
Official Title
Serum Collection Study for Assay Development
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 to 69 years
- Good general health
You will not qualify if you...
- Previous pneumococcal vaccine
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Adelaide Clinical Research Facility
Adelaide, South Australia, Australia, 5000
Actively Recruiting
Research Team
N
Nerissa Lakhan, PhD
CONTACT
P
Paul E Rolan, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here